News

Filter

Current filters:

None

Popular Filters

7894 to 7918 of 8819 results

FDA committee backs Affymax CKD drug

09-12-2011

The US Food and Drug Administration’s Oncologic Drugs Advisory Committee (ODAC) voted 15 to one,…

AffymaxNephrology and HepatologyNorth AmericaOncologypeginesatidePharmaceuticalRegulationTakeda Pharmaceuticals

Mixed views on drospirenone OCs

09-12-2011

The majority of members of the US Food and Drug Administration’s Reproductive Health Drugs Advisory…

BayerDrospirenone and EstradiolNorth AmericaPharmaceuticalRegulationReproductiveWomen's HealthYasminYaz

Overactive bladder gel gets FDA nod

09-12-2011

The US Food and Drug Administration (FDA) has approved US drugmaker Antares Pharma’s (NYSE Amex:…

Antares PharmaGenito-urinaryNorth AmericaOxybutyninPharmaceuticalRegulationWatson Pharmaceuticals

Breast cancer therapy news at SABCS

09-12-2011

This year’s CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) in Texas, USA, heard of developments…

AfinitorGenerex BiotechnologyNovartisOncologypertuzumabPharmaceuticalResearchRoche

FDA reviews Pradaxa bleeding risk

08-12-2011

Post-marketing reports of serious bleeding events in patients taking Pradaxa (dabigatran etexilate mesylate),…

Boehringer IngelheimCardio-vascularNorth AmericaPharmaceuticalPradaxaRegulation

Australia to improve therapeutics regulation

08-12-2011

The Australian government said yesterday that it will introduce a comprehensive package of reforms for…

Asia-PacificMarkets & MarketingPharmaceuticalRegulation

Sinclair IS buys derma company

08-12-2011

UK specialty drugmaker Sinclair IS Pharma plc (AIM: SPH.L) has entered into an agreement to acquire USA-based…

Advanced Bio-TechnologiesDermatologicalsKelo-coteMergers & AcquisitionsPharmaceuticalSinclair IS Pharma

MAbs largest class of biotherapeutics

08-12-2011

Monoclonal antibodies (MAbs) were the fastest growing segment in the global pharmaceutical market in…

BiotechnologyMarkets & Marketing

Chinese pharma growth forecasts

08-12-2011

Sustained double-digit growth in the Chinese pharmaceutical market from 2011 is forecast by UK-based…

Asia-PacificMarkets & MarketingPharmaceutical

AstraZeneca expands in China, cuts back in USA

08-12-2011

It was a busy couple of days for Anglo-Swedish drug major AstraZeneca (LSE: AZN), with the company yesterday…

Asia-PacificAstraZenecaGenericsGuangdong BeiKang PharmaManagementMergers & AcquisitionsNorth AmericaPharmaceutical

FDA plans biosimilars user fee talks

08-12-2011

The US Food and Drug Administration has published a Federal Register notice announcing a December 16…

BiotechnologyFinancialGenericsNorth AmericaRegulation

NICE wants more data on Daxas

08-12-2011

UK drugs watchdog the National Institute for Health and Clinical Excellence (NICE) has today issued final…

DaxasEuropeMerck & CoPharmaceuticalPricingRegulationRespiratory and Pulmonary

Dendreon cashes in Victrelis royalty

08-12-2011

US pharma company Dendreon (Nasdaq: DNDN) says that it has agreed to sell for $125 million in cash its…

Anti-viralsBiotechnologyDendreonFinancialLicensingMerck & CoOncologyPharmaceuticalProvengeVictrelis

Theratechnologies to quit COPD program

08-12-2011

Canada-based Theratechnologies (TSX: TH.TO) revealed yesterday that it is discontinuing its muscle wasting…

EgriftaFinancialNephrology and HepatologyPharmaceuticalResearchRespiratory and PulmonarytesamorelinTheratechnologies

Voraxaze out-licensed in Japan

07-12-2011

UK health care firm BTG (LSE: BGC) says that it has licensed the Japanese rights to glucarpidase (which…

Asia-PacificBTGglucarpidaseLicensingOhara PharmaceuticalOncologyPharmaceuticalVoraxaze

Diabetes Rxing in China and S Korea

07-12-2011

Dipeptidyl peptidase IV (DPP-IV) inhibitors are prescribed more commonly for the treatment of type 2…

Asia-PacificDiabetesGalvusJanuviaMarkets & MarketingMerck & CoNovartisPharmaceuticalPricing

EMA and EFPIA debate modelling

07-12-2011

Modelling and simulation methodology provides an opportunity to improve the efficiency of pharmaceutical…

EuropePharmaceuticalRegulationResearch

China to strengthen drug safety

07-12-2011

China’s State Council (Cabinet) this week approved a blueprint to establish a credit rating system…

Asia-PacificHealthcarePharmaceuticalRegulation

Generic strategic alliances

07-12-2011

The generic drugs sector’s role as the provider of affordable drugs has widely benefitted public…

GenericsMergers & Acquisitions

Biogen Idec forms JV with Korea’s Samsung for biosimilars

07-12-2011

US biotechnology firm Biogen Idec (Nasdaq: BIIB) has entered into an agreement with Korea’s largest…

Biogen IdecSamsung BioLogics

FDA eases REMS requirements for Amgen’s Nplate and GSK’s Promacta

07-12-2011

The US Food and Drug Administration says that an agency initiated review of the current information has…

AmgenBiotechnologyGlaxoSmithKlineNorth AmericaNplatePharmaceuticalPromactaRare diseasesRegulation

More cancer and HIV drugs added to Australian PBS

07-12-2011

More than 160,000 patients will benefit directly from changes to Australia’s Pharmaceutical Benefits…

AmgenAnti-viralsAsia-PacificGilead SciencesOncologyPharmaceuticalPrezistaPricingRegulationXgeva

Merck & Co commits $1.5 billion to R&D in China over next five years

07-12-2011

Adding to the flow of pharmaceutical investment into the BRIC (Brazil, Russia, India and China) countries,…

Asia-PacificFinancialMerck & CoPharmaceuticalResearch

Novartis in licensing deal with Cellectis; pays milestone to GenVec

07-12-2011

Paris, France-based Cellectis genome engineering specialist (Alternext: ALCLS) has signed a license agreement…

BiotechnologyCellectisGenVecLicensingNeurologicalNovartisPharmaceutical

7894 to 7918 of 8819 results

Back to top